“…However, in many of these studies, it has not been possible to determine the structure of the inhibitors or to clarify the nature of their interaction with Na+,K+-ATPase because many of these studies were mainly focused on obtaining evidence for the existence of the inhibitors. Only a limited number of studies including our previous studies have revealed that several compounds such as unsaturated fatty acids (Bidard et al, 1984;Tamura et al, 1985; Kelly et al, 1986), lysophosphatidylcholines (Bidard et al, 1984;Kelly et al, 1986;Tamura et al, 1987a,b), dihydroxyeicosatrienoic acid (Schwartzman et al, 1985), dopamine , dehydroepiandrosterone sulfate (Vasdev et al, 1985), lignan (Fagoo et al, 1986), and ascorbic acid (Ng et al, 1985) are endogenous substances with the inhibitory activity. However, they do not fulfill all of the criteria for an endogenous Na+,K+-ATPase inhibitor which should (i) be of low molecular weight, (ii) inhibits Na+,K+-ATPase, (iii) displaces [3H]ouabain bound to the enzyme, (iv) inhibits Na+,K+ pump activity, (v) cross-reacts with anti-digoxin antibody, and (vi) does not interfere with other ATPase.…”